Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N‐terminal d‐Trp or d‐Tpi
- 1 December 1991
- journal article
- Published by Wiley in International Journal of Peptide and Protein Research
- Vol. 38 (6) , 593-600
Abstract
In an attempt to produce more powerful (effective) bombesin/GRP receptor antagonists, the d forms of Trp or Trp analog (Tpi) were introduced at position 6 in two pseudononapeptides, Leu13Ψ (CH2NH)Leu14‐bombesin(6‐14) and Leu13Ψ(CH2NH)Phe14 ‐bombesin (6‐14). These antagonists were tested for their ability to inhibit basal and gastrin releasing peptide (GRP) (14‐27)‐induced amylase release from rat pancreatic acini in a superfusion assay. They were also assessed for the inhibition of 125I‐Tyr4 ‐bombesin binding to Swiss 3T3 and small cell lung carcinoma cell line H‐345 and the mitogenic response of Swiss 3T3 cells induced by GRP(14‐27). The peptides, when given alone, did not stimulate amylase secretion, but were able to inhibit gastrin releasing peptide (14‐27)‐induced amylase release. All of the antagonists showed strong binding affinities for Swiss 3T3 and H‐345 cells and suppressed the GRP(14‐27)‐induced increase of [3H]thymidine incorporation into DNA of Swiss 3T3 cells at nanomolar concentrations. Antagonist d‐Tpi6,Leu13Ψ (CH2NH)Leu14‐bombesin (6‐14)(RC‐3095) was slightly more potent in these assays than d‐Trp6,Leu13Ψ (CH2NH)Leu14‐bombesin (6‐14)(RC‐3125). Nevertheless, d‐Trp6 Leu13Ψ (CH2NH)Phe14‐bombesin (6‐14) showed the highest binding affinity for Swiss 3T3 and H345 cells and it was the most potent inhibitor of GRP(14‐27)‐induced amylase secretion. This antagonist RC‐3420 was particularly effective in inhibiting the growth of Swiss 3T3 cells, exhibiting an IC50 value less than 1 nm. Our work indicated that the substitution of d‐Trp and d‐Tpi at position 6 of the pseudononapeptide bombesin analogs (Ψ13‐14), in which the Met14 residue is replaced by Leu or Phe, results in potent bombesin/GRP antagonists with improved in vivo activity.Keywords
This publication has 41 references indexed in Scilit:
- Characterization of the bombesin receptor on mouse pancreatic acini by chemical cross-linkingPeptides, 1990
- NisobutyrylHisTrpAlaValDAlaHisLeuNHMe (ICI 226140) a potent antagonist analogue of bombesin/gastrin releasing peptide (BN/GRP) derived from the c-terminal sequence lacking the final methionine residueLife Sciences, 1989
- (D‐Phe12) bombesin and substance P analogues function as central bombesin receptor antagonistsSynapse, 1988
- II. Central nervous system action of bombesin to inhibit gastric acid secretionLife Sciences, 1985
- Bombesin-like immunoreactivity in the pancreas of man and other mammalian speciesCellular and Molecular Life Sciences, 1984
- Neuromedin C: A bombesin-like peptide identified in porcine spinal cordBiochemical and Biophysical Research Communications, 1984
- Neuromedin B: A novel bombesin-like peptide identified in porcine spinal cordBiochemical and Biophysical Research Communications, 1983
- Characterization of a gastrin releasing peptide from porcine non-antral gastric tissueBiochemical and Biophysical Research Communications, 1979
- A gastrin releasing peptide from the porcine nonantral gastric tissue.Gut, 1978
- A SENSITIVE METHOD FOR THE DETECTION OF CORTICOTROPHIN RELEASING FACTOR USING A PERFUSED PITUITARY CELL COLUMNJournal of Endocrinology, 1974